Capital Investment Advisors LLC Buys 218 Shares of Agilent Technologies, Inc. $A

Capital Investment Advisors LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 7.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,027 shares of the medical research company’s stock after acquiring an additional 218 shares during the quarter. Capital Investment Advisors LLC’s holdings in Agilent Technologies were worth $357,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC lifted its position in Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after acquiring an additional 186 shares in the last quarter. Stone House Investment Management LLC bought a new stake in Agilent Technologies in the 1st quarter valued at $30,000. Opal Wealth Advisors LLC bought a new stake in Agilent Technologies in the 1st quarter valued at $31,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies in the 1st quarter valued at $32,000. Finally, Central Pacific Bank Trust Division bought a new stake in Agilent Technologies in the 2nd quarter valued at $33,000.

Analyst Upgrades and Downgrades

A has been the topic of several analyst reports. Robert W. Baird boosted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Barclays boosted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday. Evercore ISI cut their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a research report on Thursday, August 28th. Finally, Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $142.17.

Agilent Technologies Stock Up 0.1%

Shares of A stock opened at $138.66 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The firm’s 50-day moving average is $122.36 and its 200-day moving average is $116.28. The stock has a market cap of $39.31 billion, a price-to-earnings ratio of 32.55, a PEG ratio of 4.52 and a beta of 1.26. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.